ESR1 and invasive breast carcinoma: According to the assessment of immunohistochemistry (IHC), the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) was found to be 80%, 60–70%, and 15–20%, respectively, in all invasive breast carcinomas [8,9,10].